Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06721507 · ClinicalTrials.gov registry record · Phase 4
2024 Tirzepatide-Bariatric Surgery
A Phase 4 study of Bariatric Surgery and Obesity and Obesity-related Medical Conditions, sponsored by Marlene Starr.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06721507 is a Phase 4 study of Bariatric Surgery and Obesity and Obesity-related Medical Conditions that is actively recruiting participants, run by Marlene Starr. The registered enrollment target is 50 participants, below the 96-participant average among 15 other Bariatric Surgery trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06721507, a Phase 4 study of Bariatric Surgery and Obesity and Obesity-related Medical Conditions, is actively recruiting participants, sponsored by Marlene Starr.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial will test whether preoperative tirzepatide treatment improves outcomes after bariatric surgery. The outcome of this study could impact therapeutic guidelines for the multimodal treatment of obesity. The major objectives are: 1. To evaluate whether pre-operative tirzepatide treatment reduces tissue and circulating inflammatory markers at the time of surgery. 2. To establish the relationship of these changes with postoperative improvements in weight loss, metabolic and inflammatory profiles, comorbidity resolution (glycemic control, blood pressure, lipid profile), and 30-day surgical complications. Researchers will compare data from patients taking tirzepatide to data from patients not taking tirzepatide before their planned bariatric surgery to see if tirzepatide reduces inflammation and improves health outcomes after bariatric surgery. Participants will: Take or not take tirzepatide, depending on what study group they are in, once a week for 3 months. Visit the endocrine clinic once a month for 3 months to be prescribed the drug and for checkups regarding side effects due to the drug. Keep a diary to document taking the drug and any side effects. Continue with their planned bariatric surgery and post-surgery follow-ups according to their healthcare provider.
Conditions Studied
Interventions
- BEHAVIORAL Standard of Care
- DRUG tirzepatide
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-03-27 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06721507
The ClinicalTrials.gov registry entry for NCT06721507 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 96-participant average among 15 other Bariatric Surgery trials with a reported enrollment target (48% lower). The listed sponsor is Marlene Starr, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bariatric Surgery appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT06721507 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT06721507 about?
NCT06721507 is a clinical study titled "2024 Tirzepatide-Bariatric Surgery". This clinical trial will test whether preoperative tirzepatide treatment improves outcomes after bariatric surgery. The outcome of this study could impact therapeutic guidelines for the multimodal treatment of obesity. The major objectives are: 1. To evaluate whether pre-operative tirzepatide trea...
What is the current status of trial NCT06721507?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2025-03-27. Estimated completion is 2026-12-31.
What conditions does trial NCT06721507 study?
This clinical trial studies the following conditions: Bariatric Surgery, Obesity and Obesity-related Medical Conditions.
What interventions are being tested in trial NCT06721507?
The interventions under investigation include: Standard of Care (BEHAVIORAL), tirzepatide (DRUG).
Who is sponsoring clinical trial NCT06721507?
This trial is sponsored by Marlene Starr, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06721507 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bariatric Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Simethicone as Part of ERAS in Bariatric Surgery Patients
RECRUITING · Phase 4
-
Glucagon Dose-Response in Patients With Post-Bariatric Hypoglycemia
ACTIVE NOT RECRUITING · Phase 4
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents
RECRUITING · Phase 1
-
Oral Acetaminophen for Post-Op Pain Management in Bariatric Surgery Patients
RECRUITING · Phase 2
-
Lexion AP 50/30 Warmed Humidified Real Time CO2 Insufflation vs Airseal Recirculated CO2/Air Insufflation in Minimally Invasive Bariatric (Gastric Bypass) Surgery
RECRUITING · NA
Explore more on PlainTrial
Bariatric Surgery
All registered trials for this condition
Obesity and Obesity-related Medical Conditions
All registered trials for this condition
Kentucky
All trials with a study site in Kentucky
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.